Precipio, Inc. (PRPO)
NASDAQ: PRPO · Real-Time Price · USD
8.38
+0.01 (0.06%)
May 19, 2025, 4:00 PM - Market open
Precipio Revenue
Precipio had revenue of $4.93M in the quarter ending March 31, 2025, with 43.62% growth. This brings the company's revenue in the last twelve months to $20.03M, up 26.67% year-over-year. In the year 2024, Precipio had annual revenue of $18.53M with 21.95% growth.
Revenue (ttm)
$20.03M
Revenue Growth
+26.67%
P/S Ratio
0.62
Revenue / Employee
$333,817
Employees
60
Market Cap
12.60M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 18.53M | 3.34M | 21.95% |
Dec 31, 2023 | 15.20M | 5.79M | 61.46% |
Dec 31, 2022 | 9.41M | 563.00K | 6.36% |
Dec 31, 2021 | 8.85M | 2.76M | 45.26% |
Dec 31, 2020 | 6.09M | 2.97M | 94.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
PRPO News
- 4 days ago - Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Precipio Announces its Q1-2025 Financial Results - GlobeNewsWire
- 18 days ago - Precipio Announces Q1-2025 Shareholder Update Call - GlobeNewsWire
- 7 weeks ago - Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Precipio Announces Q4 and year-end 2024 Shareholder Update Call - GlobeNewsWire
- 2 months ago - Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited) - GlobeNewsWire
- 4 months ago - Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs - GlobeNewsWire
- 6 months ago - Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript - Seeking Alpha